| Product Name | MF | CAS | Details |
|---|
| Tetramer/BV421 – H-2 Kb LCMV (ISHNFCNL) | Details |
| Tetramer/BV421 – HLA – A*02:01 Melanoma – KTWGQYWQV | Details |
| Tetramer/BV421 – HLA-A*02:01 NY-ESO-1 C9V (SLLMWITQV) | Details |
| Tetramer/BV421 – HLA-A*0201 Her-2/neu (KIFGSLAFL) | Details |
| Tetramer/BV421 – HLA-A*0201 Influenza-M1 (GILGFVFTL) | Details |
| Tetramer/BV421 – HLA-A*03:01htert K973 (KLFGVLRLK) | Details |
| Tetramer/BV421 – Mafa-A1*063 SIV gag GW9 (GPRKPIKCW) | Details |
| Tetramer/BV421 – Mamu-A*01 SIV gag (CTPYDINQM) | Details |
| Tetramer/PE – HLA-A*02:01Mesothelin (20-28) (SLLFLLFSL) | Details |
| Tetramer/PE – HLA-A*03:01htert K973 (KLFGVLRLK) | Details |
| Tetramer/BV421 – H-2 Db SV40 large T Ag 206-215 (SAINNYAQKL) | Details |
| Tetramer/BV421 – H-2 Kd RSV M2 (SYIGSINNI) | Details |
| Tetramer/BV421 – HLA-A*01:01 MAGE-A3 (EVDPIGHLY) | Details |
| Tetramer/BV421 – HLA-A*0201 Gp 100 (ITDQVPFSV) | Details |
| Tetramer/BV421 – HLA-A*0201 HIV pol (ILKEPVHGV) | Details |
| Tetramer/BV421 – HLA-A*2402 HBV core (EYLVSFGVW) | Details |
| Tetramer/BV421 – HLA-B*27:05 NP(383-391) (SRYWAIRTR) | Details |
| Tetramer/PE – H-2 Kd MAGE-A3 (SYVKVLHHM) | Details |
| Tetramer/PE – HLA-A*02:01hTERT Y572 (YLFFYRKSV) | Details |
| Tetramer/PE – HLA-B*57:01 HIV gag (147-155) (ISPRTLNAW) | Details |
| Tetramer/BV421 – H-2 Kb Survivin (MFFCFKEL) | Details |
| Tetramer/BV421 – H-2 Kd HIV gag (AMQMLKETI) | Details |
| Tetramer/BV421 – HLA-A*02:01IGRP (228-236) (LNIDLLWSV) | Details |
| Tetramer/BV421 – HLA-A*02:01MAGE-A10 (GLYDGMEHL) | Details |
| Tetramer/BV421 – HLA-A*0201 Tyrosinase (YMDGTMSQV) | Details |
| Tetramer/BV421 – HLA-A*03:01EBV EBNA3A (603-611) (RLRAEAQVK) | Details |
| Tetramer/BV421 – Mafa-B*104:01 SIV nef LT9 (LNMADKKET) | Details |
| Tetramer/PE – H-2 Kb Toxoplasma gondii tgd057 (SVLAFRRL) | Details |
| Tetramer/PE – HLA-A*03:01HIV p17 gag (20-28) (RLRPGGKKK) | Details |
| Tetramer/PE – HLA-A*24:02 WT1 (mutant) (CYTWNQMNL) | Details |
| Tetramer/BV421 – H-2 Kb LCMV (LEYDFNKL) | Details |
| Tetramer/BV421 – H-2 Kb TRP2 (SVYDFFVWL) | Details |
| Tetramer/BV421 – HLA-A*02:01 WT-1 (RMFPNAPYL) | Details |
| Tetramer/BV421 – HLA-A*02:01Mesothelin (20-28) (SLLFLLFSL) | Details |
| Tetramer/BV421 – HLA-A*0201 Mart-1 (ELAGIGILTV) | Details |
| Tetramer/BV421 – HLA-A*03:01Influenza Virus NP (265-274) (ILRGSVAHK) | Details |
| Tetramer/BV421 – Mafa-A1*063 SIV nef HW8 (HPAQTSQW) | Details |
| Tetramer/BV421 -Qa-1b Qdm (AMAPRTLLL) | Details |
| Tetramer/PE – HLA-A*02:01Mesothelin (530-538) (VLPLTVAEV) | Details |
| Tetramer/PE – HLA-A*03:01Influenza Virus NP (265-274) (ILRGSVAHK) | Details |
| Tetramer/BV421 – H-2 Kb LCMV (AVYNFATC) | Details |
| Tetramer/BV421 – HLA – A*02:01 HCV NS3 (CINGVCWTV) | Details |
| Tetramer/BV421 – HLA-A*0101 CMV (VTEHDTLLY) | Details |
| Tetramer/BV421 – HLA-A*0201 Gp100 (IMDQVPFSV) | Details |
| Tetramer/BV421 – HLA-A*0201 HPV (YMLDLQPET) | Details |
| Tetramer/BV421 – HLA-A*2402 HBV pol (KYTSFPWLL) | Details |
| Tetramer/BV421 – HLA-B*3501 CMV (IPSINVHHY) | Details |
| Tetramer/PE – H-2 Kd Plasmodium CSP (280-288) (SYVPSAEQI) | Details |
| Tetramer/PE – HLA-A*02:01IGRP (228-236) (LNIDLLWSV) | Details |
| Tetramer/PE – Mafa-A1*063 SIV gag GW9 (GPRKPIKCW) | Details |
| Tetramer/BV421 – H-2 Kb Toxoplasma gondii tgd057 (SVLAFRRL) | Details |
| Tetramer/BV421 – H-2 Kd MAGE-A3 (SYVKVLHHM) | Details |
| Tetramer/BV421 – HLA-A*02:01Insulin B.10 (HLVEALYLV) | Details |
| Tetramer/BV421 – HLA-A*0201 CMV PP65 (NLVPMVATV) | Details |
| Tetramer/BV421 – HLA-A*03:01HIV p17 gag (20-28) (RLRPGGKKK) | Details |
| Tetramer/BV421 – HLA-A*24:02 WT1 (mutant) (CYTWNQMNL) | Details |
| Tetramer/BV421 – HLA-B*0801 CMV (ELRRKMMYM) | Details |
| Tetramer/PE – H-2 Kb VACV B8R (TSYKFESV) | Details |
| Tetramer/PE – HLA-A*02:01 Tyrosinase (YMDGTMSQV) | Details |
| Tetramer/PE – HLA-B*27:05 HIV gag (263-272) (KRWIIMGLNK) | Details |
| Tetramer/BV421 – H-2 Kb LCMV (YTVKYPNL) | Details |
| Tetramer/BV421 – H-2 Kb VACV B8R (TSYKFESV) | Details |
| Tetramer/BV421 – HLA-A*02:01hTERT D988Y (YLQVNSLQTV) | Details |
| Tetramer/BV421 – HLA-A*02:01Mesothelin (530-538) (VLPLTVAEV) | Details |
| Tetramer/BV421 – HLA-A*0201 NY-ESO-1 (SLLMWITQC) | Details |
| Tetramer/BV421 – HLA-A*03:01Survivin (18-27)(modK) (RISTFKNWPK) | Details |
| Tetramer/BV421 – Mafa-A1*063 SIV nef RM9 (RPKVPLRTM) | Details |
| Tetramer/PE – H-2 Db MHV S protein (510-518) (CSLWNGPHL) | Details |
| Tetramer/PE – HLA-A*02:01EBV LMP2 (426-434) (CLGGLLTMV) | Details |
| Tetramer/PE – HLA-A*03:01Survivin (18-27)(modK) (RISTFKNWPK) | Details |
| Tetramer/BV421 – H-2 Kb LCMV (AVYNFATCGI) | Details |
| Tetramer/BV421 – HLA – A*02:01 MAGE-A1 (KVLEYVIKV) | Details |
| Tetramer/BV421 – HLA-A*02:01 HIV gag (SLYNTVATL) | Details |
| Tetramer/BV421 – HLA-A*0201 HBV core (FLPSDFFPSV) | Details |
| Tetramer/BV421 – HLA-A*0201 HTLV-1 (LLFGYPVYV) | Details |
| Tetramer/BV421 – HLA-B*0702 CMV (TPRVTGGGAM) | Details |
| Tetramer/BV421 – HLA-B*57:01 HIV gag (147-155) (ISPRTLNAW) | Details |
| Tetramer/PE – HLA – B*15:01EBNA4 (GQGGSPTAM) | Details |
| Tetramer/PE – HLA-A*02:01Insulin B.10 (HLVEALYLV) | Details |
| Tetramer/PE – Mafa-A1*063 SIV nef HW8 (HPAQTSQW) | Details |
| Tetramer/BV421 – H-2 Db SIV GAG (AAVKNWMTQTL) | Details |
| Tetramer/BV421 – H-2 Kd Plasmodium CSP (280-288) (SYVPSAEQI) | Details |
| Tetramer/BV421 – HLA – B*15:01EBNA4 (GQGGSPTAM) | Details |
| Tetramer/BV421 – HLA-A*0201 EBV (GLCTLVAML) | Details |
| Tetramer/BV421 – HLA-A*0201 Her-2/neu (RLLQETELV) | Details |
| Tetramer/BV421 – HLA-A*2402 CMV (QYDPVAALF) | Details |
| Tetramer/BV421 – HLA-B*27:05 HIV gag (263-272) (KRWIIMGLNK) | Details |
| Tetramer/PE – H-2 Kd Fibrosarcoma neoepitope Tnpo3 (SYMLQALCI) | Details |
| Tetramer/PE – HLA-A*02:01hTERT D988Y (YLQVNSLQTV) | Details |
| Tetramer/PE – HLA-B*27:05 NP(383-391) (SRYWAIRTR) | Details |
| Tetramer/BV421 – H-2 Kb OVA (SIINFEKL) | Details |
| Tetramer/BV421 – H-2 Kd Fibrosarcoma neoepitope Tnpo3 (SYMLQALCI) | Details |
| Tetramer/BV421 – HLA-A*02:01hTERT Y572 (YLFFYRKSV) | Details |
| Tetramer/BV421 – HLA-A*02:01EBV LMP2 (426-434) (CLGGLLTMV) | Details |
| Tetramer/BV421 – HLA-A*0201 PR-1 (VLQELNVTV) | Details |
| Tetramer/BV421 – HLA-A*03:01 (20-28) EBV BRLF1 (RVRAYTYSK) | Details |
| Tetramer/BV421 – Mafa-B*104:01 SIV gag NA9 (NCVGDHQAA) | Details |
| Tetramer/PE – H-2 Kb Survivin (MFFCFKEL) | Details |
| Tetramer/PE – HLA-A*02:01MAGE-A10 (GLYDGMEHL) | Details |
| Tetramer/PE – HLA-A*03:01EBV EBNA3A (603-611) (RLRAEAQVK) | Details |
| Product Total： Product Page： | ||||
| 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 | ||||